These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9699620)

  • 1. Structure of the gangrene alpha-toxin: the beauty in the beast.
    Derewenda ZS; Martin TW
    Nat Struct Biol; 1998 Aug; 5(8):659-62. PubMed ID: 9699620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of the key toxin in gas gangrene.
    Naylor CE; Eaton JT; Howells A; Justin N; Moss DS; Titball RW; Basak AK
    Nat Struct Biol; 1998 Aug; 5(8):738-46. PubMed ID: 9699639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the calcium-binding C-terminal domain of Clostridium perfringens alpha-toxin.
    Naylor CE; Jepson M; Crane DT; Titball RW; Miller J; Basak AK; Bolgiano B
    J Mol Biol; 1999 Dec; 294(3):757-70. PubMed ID: 10610794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the C. perfringens alpha-toxin with the active site closed by a flexible loop region.
    Eaton JT; Naylor CE; Howells AM; Moss DS; Titball RW; Basak AK
    J Mol Biol; 2002 May; 319(2):275-81. PubMed ID: 12051905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification, crystallization and preliminary X-ray diffraction studies of alpha-toxin of Clostridium perfringens.
    Basak AK; Stuart DI; Nikura T; Bishop DH; Kelly DC; Fearn A; Titball RW
    J Mol Biol; 1994 Dec; 244(5):648-50. PubMed ID: 7990145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium perfringens alpha-toxin: characterization and mode of action.
    Sakurai J; Nagahama M; Oda M
    J Biochem; 2004 Nov; 136(5):569-74. PubMed ID: 15632295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The solution structure of the C-terminal modular pair from Clostridium perfringens mu-toxin reveals a noncellulosomal dockerin module.
    Chitayat S; Adams JJ; Furness HS; Bayer EA; Smith SP
    J Mol Biol; 2008 Sep; 381(5):1202-12. PubMed ID: 18602403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a nontoxic variant of Clostridium perfringens α-toxin with the toxic wild-type strain.
    Vachieri SG; Clark GC; Alape-Girón A; Flores-Díaz M; Justin N; Naylor CE; Titball RW; Basak AK
    Acta Crystallogr D Biol Crystallogr; 2010 Oct; 66(Pt 10):1067-74. PubMed ID: 20944240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first strain of Clostridium perfringens isolated from an avian source has an alpha-toxin with divergent structural and kinetic properties.
    Justin N; Walker N; Bullifent HL; Songer G; Bueschel DM; Jost H; Naylor C; Miller J; Moss DS; Titball RW; Basak AK
    Biochemistry; 2002 May; 41(20):6253-62. PubMed ID: 12009886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against Clostridium perfringens alpha-toxin.
    Nagahama M
    Curr Pharm Biotechnol; 2013; 14(10):913-7. PubMed ID: 24372250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of residues in the carboxy-terminal domain of Clostridium perfringens alpha-toxin (phospholipase C) which are required for its biological activities.
    Walker N; Holley J; Naylor CE; Flores-Díaz M; Alape-Girón A; Carter G; Carr FJ; Thelestam M; Keyte M; Moss DS; Basak AK; Miller J; Titball RW
    Arch Biochem Biophys; 2000 Dec; 384(1):24-30. PubMed ID: 11147832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gas gangrene--case diagnosis].
    Wojdat E; Kwiatek K; Zdrojewski H; Krupa L
    Przegl Epidemiol; 2005; 59(4):859-63. PubMed ID: 16729427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clostridium perfringens and gas gangrene].
    Lindsay D
    Zentralbl Chir; 1986; 111(6):314-23. PubMed ID: 2872759
    [No Abstract]   [Full Text] [Related]  

  • 14. Phospholipase C and sphingomyelinase activities of the Clostridium perfringens alpha-toxin.
    Urbina P; Flores-Díaz M; Alape-Girón A; Alonso A; Goni FM
    Chem Phys Lipids; 2009 May; 159(1):51-7. PubMed ID: 19428363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opening of the active site of Clostridium perfringens alpha-toxin may be triggered by membrane binding.
    Titball RW; Naylor CE; Miller J; Moss DS; Basak AK
    Int J Med Microbiol; 2000 Oct; 290(4-5):357-61. PubMed ID: 11111911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues.
    O'Brien DK; Melville SB
    Infect Immun; 2004 Sep; 72(9):5204-15. PubMed ID: 15322015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-complementation of Clostridium perfringens PLC and Clostridium septicum alpha-toxin mutants reveals PLC is sufficient to mediate gas gangrene.
    Kennedy CL; Lyras D; Cheung JK; Hiscox TJ; Emmins JJ; Rood JI
    Microbes Infect; 2009 Mar; 11(3):413-8. PubMed ID: 19284973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of diphtheria toxin.
    Choe S; Bennett MJ; Fujii G; Curmi PM; Kantardjieff KA; Collier RJ; Eisenberg D
    Nature; 1992 May; 357(6375):216-22. PubMed ID: 1589020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipid hydrolysis caused by Clostridium perfringens α-toxin facilitates the targeting of perfringolysin O to membrane bilayers.
    Moe PC; Heuck AP
    Biochemistry; 2010 Nov; 49(44):9498-507. PubMed ID: 20886855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational changes and reaction of clostridial glycosylating toxins.
    Ziegler MO; Jank T; Aktories K; Schulz GE
    J Mol Biol; 2008 Apr; 377(5):1346-56. PubMed ID: 18325534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.